BC is classified into three categories depending on clinical and histopathological characteristics and the expression of progesterone receptor (PR), estrogen receptor (ER), human epidermal growth factor receptor 2-related protein (HER2), and Ki67 (2). This evidence concerns the gene ERBB2 and breast cancer.